Clinical Trial Update: ENDOBARRIER® and Conventional Therapy in the Management of Metabolic Syndrome in Obese Patients [NA]

View source ↗

Summary

A clinical trial evaluating ENDOBARRIER with conventional therapy for metabolic syndrome in obese patients has been terminated at the University Hospital, Lille…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Syndrome

Drugs mentioned

• EndoBarrier (duodenal-jejunal bypass liner)

Snippet

Sponsor: University Hospital, Lille | Conditions: Metabolic Syndrome | NA | Status: TERMINATED